open access

Vol 5, Supp. A (2009)
suplement
Published online: 2009-04-29
Get Citation

Antiangiogenic treatment in patients with hepatocellular carcinoma

Krzysztof Krzemieniecki

open access

Vol 5, Supp. A (2009)
suplement
Published online: 2009-04-29

Abstract

Hepatocellular carcinoma (HCC) is usually diagnosed in advanced stage and numerous of patients present poor clinical condition which is a reason for small fraction of patients treated with surgery. Among operated patients, high percentage presents inoperable recurrence of the cancer. Introduction of effective systemic treatment is necessary in this group of patients. Antiangiogenetic agents are the first active class of medications used in advanced HCC. These drugs are recently tested in adjuvant setting after successful surgery in less advanced cases of HCC. Combinations of antiangiogenetic agents and other drugs of molecular targeted therapies are searched.

Abstract

Hepatocellular carcinoma (HCC) is usually diagnosed in advanced stage and numerous of patients present poor clinical condition which is a reason for small fraction of patients treated with surgery. Among operated patients, high percentage presents inoperable recurrence of the cancer. Introduction of effective systemic treatment is necessary in this group of patients. Antiangiogenetic agents are the first active class of medications used in advanced HCC. These drugs are recently tested in adjuvant setting after successful surgery in less advanced cases of HCC. Combinations of antiangiogenetic agents and other drugs of molecular targeted therapies are searched.
Get Citation

Keywords

hepatocellular carcinoma; angiogenesis; molecular targeted therapy

About this article
Title

Antiangiogenic treatment in patients with hepatocellular carcinoma

Journal

Oncology in Clinical Practice

Issue

Vol 5, Supp. A (2009)

Pages

44-47

Published online

2009-04-29

Keywords

hepatocellular carcinoma
angiogenesis
molecular targeted therapy

Authors

Krzysztof Krzemieniecki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl